S R Group

This ELISA kit uses quantitative-ELISA as the method. The Micro-elisa strip plate provided in this kit has been pre-coated with an antibody specific to cardiac isoform of Tropnin T (cTnT). Standards or samples are added to the appropriate Micro-elisa strip plate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for cardiac isoform of Tropnin T (cTnT) is added to each Micro-elisa strip plate well and incubated. Free components are washed away. The TMB substrate solution is added to each well. Only those wells that contain cardiac isoform of Tropnin T (cTnT) and HRP conjugated cardiac isoform of Tropnin T (cTnT) antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm. The OD value is proportional to the concentration of cardiac isoform of Tropnin T (cTnT). You can calculate the concentration of cardiac isoform of Tropnin T (cTnT) in the samples by comparing the OD of the samples to the standard curve.

Gene Names:SOOther Names:Human Antistreptolysin O ELISA Kit; ascorbate oxidaseHost/Reactivities:Reactivity: HumanAssay TypeQuantitative SandwichDetection Range25IU/ml-800IU/mlSensitivity5.0IU/ml

The RT-PCR (Reverse Transcription Polymerase Chain Reaction) kit diagnostic principle is based on the detection and amplification of specific RNA sequences from pathogens (like viruses) by converting them into complementary DNA (cDNA) and then exponentially amplifying that DNA in real-time

The RT-PCR (Reverse Transcription Polymerase Chain Reaction) kit diagnostic principle is based on the detection and amplification of specific RNA sequences from pathogens (like viruses) by converting them into complementary DNA (cDNA) and then exponentially amplifying that DNA in real-time

The RT-PCR (Reverse Transcription Polymerase Chain Reaction) kit diagnostic principle is based on the detection and amplification of specific RNA sequences from pathogens (like viruses) by converting them into complementary DNA (cDNA) and then exponentially amplifying that DNA in real-time

The RT-PCR (Reverse Transcription Polymerase Chain Reaction) kit diagnostic principle is based on the detection and amplification of specific RNA sequences from pathogens (like viruses) by converting them into complementary DNA (cDNA) and then exponentially amplifying that DNA in real-time

The RT-PCR (Reverse Transcription Polymerase Chain Reaction) kit diagnostic principle is based on the detection and amplification of specific RNA sequences from pathogens (like viruses) by converting them into complementary DNA (cDNA) and then exponentially amplifying that DNA in real-time

The RT-PCR (Reverse Transcription Polymerase Chain Reaction) kit diagnostic principle is based on the detection and amplification of specific RNA sequences from pathogens (like viruses) by converting them into complementary DNA (cDNA) and then exponentially amplifying that DNA in real-time

The RT-PCR (Reverse Transcription Polymerase Chain Reaction) kit diagnostic principle is based on the detection and amplification of specific RNA sequences from pathogens (like viruses) by converting them into complementary DNA (cDNA) and then exponentially amplifying that DNA in real-time

The RT-PCR (Reverse Transcription Polymerase Chain Reaction) kit diagnostic principle is based on the detection and amplification of specific RNA sequences from pathogens (like viruses) by converting them into complementary DNA (cDNA) and then exponentially amplifying that DNA in real-time

The RT-PCR (Reverse Transcription Polymerase Chain Reaction) kit diagnostic principle is based on the detection and amplification of specific RNA sequences from pathogens (like viruses) by converting them into complementary DNA (cDNA) and then exponentially amplifying that DNA in real-time

Gene Names:TNNT2Other Names:CMH2; cTnT; TnTc; Cardiomyopathy,Hypertrophic 2; Cardiac muscle troponin T; troponin T type 2; cardiacHost/Reactivities:Reactivity: HumanAssay TypeDouble-antibody SandwichSamplesSerum, Plasma, Tissue homogenates, Cell lysates, Cell culture supernates and other biological fluidsDetection Range15.6-1,000pg/mLSensitivity6.4pg/mL

Addition Information :
The Seegene Covid-19 RT PCR Kit is a state-of-the-art diagnostic tool designed for the accurate and rapid detection of the SARS-CoV-2 virus, responsible for COVID-19. This kit employs advanced real-time polymerase chain reaction (RT-PCR) technology, ensuring high sensitivity and specificity in identifying viral RNA from respiratory samples. Each kit contains all necessary reagents, including primers and probes, optimized for reliable performance, making it suitable for both clinical laboratories and research settings. With its user-friendly protocol, the Seegene Covid-19 RT PCR Kit allows for streamlined testing processes, enabling healthcare professionals to deliver timely results. By choosing this kit, you are investing in a trusted solution that enhances your ability to combat the pandemic effectively, ensuring the safety and health of your community.

The Human Cardiac Troponin I (cTnI/TNNI3) ELISA Kit is a laboratory tool designed to quantitatively measure cTnI levels in human samples like serum, plasma, and cell lysates, using a sensitive, sandwich, or competitive enzyme-linked immunosorbent assay. It is primarily used for research on cardiac muscle injury, such as myocarditis or infarction, offering high specificity and a range typically detecting in the pg/mLpg/mLpg/mL range. 

The RT-PCR (Reverse Transcription Polymerase Chain Reaction) kit diagnostic principle is based on the detection and amplification of specific RNA sequences from pathogens (like viruses) by converting them into complementary DNA (cDNA) and then exponentially amplifying that DNA in real-time

Our highly cited primary, secondary, and recombinant monoclonal antibodies have you covered for your ELISA, Western blot, immunohistochemistry, or other assay needs. We are proud to offer brands you know and trust, including Sigma-Aldrich

 Anti-hRANKL-hIgG2 is a biosimilar antibody of Denosumab, a therapeutic antibody that targets the human RANKL (receptor activator of nuclear factor-κB ligand, or TNFSF11). This monoclonal antibody (mAb) blocks the interaction of RANKL with its receptor. The FDA has approved Denosumab for the treatment of osteoporosis and bone metastasis.

Anti-hRANKL-hIgG2 comprises the variable region of Denosumab and the IgG2 constant region of Denosumab with high effector functions.

This antibody can be used with HEK-Blue™ RANKL cells for screening and neutralization assays to block recombinant human RANKL -induced signaling

This assay uses the quantitative enzyme immunoassay method. The provided microtiter plate in the kit is pre-coated with cTnT/TNNT2(Troponin T Type 2, Cardiac). Standards or samples are added to the appropriate wells of the microtiter plate, along with a biotin-conjugated antibody specific to cTnT/TNNT2(Troponin T Type 2, Cardiac). Then, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each well and incubated. Following this, TMB substrate solution is added. Only the wells that contain cTnT/TNNT2(Troponin T Type 2, Cardiac), biotin-conjugated antibody, and enzyme-conjugated Avidin will show a color change. The enzyme-substrate reaction is stopped by adding a sulfuric acid solution, and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of cTnT/TNNT2(Troponin T Type 2, Cardiac) in the samples is determined by comparing the optical density (OD) of the samples to the standard curve.

This ELISA kit uses quantitative-ELISA as the method. The Micro-elisa strip plate provided in this kit has been pre-coated with an antibody specific to cardiac troponin I. Standards or samples are added to the appropriate Micro-elisa strip plate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for cardiac troponin I is added to each Micro-elisa strip plate well and incubated. Free components are washed away. The TMB substrate solution is added to each well. Only those wells that contain cardiac troponin I and HRP conjugated cardiac troponin I antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm. The OD value is proportional to the concentration of cardiac troponin I

A CD22 recombinant monoclonal antibody targets the CD22 protein (Siglec-2) on mature B-cells, acting as a specific marker for B-cell identification, differentiation, and lymphomas, regulating B-cell receptor signaling via sialic acid binding and ITIM motifs, making it crucial for research and potential diagnostics in B-cell malignancies. These antibodies are engineered for high specificity and affinity, often "humanized" to reduce immunogenicity, and used in flow cytometry, IHC, and potentially for targeted therapies. 

CUSABIO's CD45 description highlights it as a key Leukocyte Common Antigen (LCA), a transmembrane protein tyrosine phosphatase found on all hematopoietic cells (except mature RBCs) crucial for immune cell activation and differentiation, used in diagnostics (like lymphoma) and research (stem cell characterization, flow cytometry). CUSABIO offers various CD45 products (antibodies, ELISA kits, proteins) for detecting this vital marker, essential for distinguishing immune cell types and understanding immune responses.